{"id":1068240,"date":"2022-06-28T01:47:40","date_gmt":"2022-06-28T05:47:40","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/sellas-life-sciences-provides-clinical-update-for-gfh009-ongoing-phase-1-clinical-trial\/"},"modified":"2024-08-18T11:44:46","modified_gmt":"2024-08-18T15:44:46","slug":"sellas-life-sciences-provides-clinical-update-for-gfh009-ongoing-phase-1-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sellas-life-sciences-provides-clinical-update-for-gfh009-ongoing-phase-1-clinical-trial.php","title":{"rendered":"SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial"},"content":{"rendered":"<p><![CDATA[- No Dose-Limiting Toxicities Observed in Lymphoma and Acute Myeloid Leukemia Patients at All Dose Levels Studied To-Date\u00a0-]]><\/p>\n<p>Continued here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/27\/2469533\/0\/en\/SELLAS-Life-Sciences-Provides-Clinical-Update-for-GFH009-Ongoing-Phase-1-Clinical-Trial.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial\">SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continued here: SELLAS Life Sciences Provides Clinical Update for GFH009 Ongoing Phase 1 Clinical Trial <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sellas-life-sciences-provides-clinical-update-for-gfh009-ongoing-phase-1-clinical-trial.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068240","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068240"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068240"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068240\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}